Cipla
Leuprollide Depot
Manufacturer:
Cipla
Name:
Leuprollide Depot
HCPCS Code Descriptor:
Injection, leuprolide acetate for depot suspension (cipla), 7.5 mg
Category:
J Code
HCPCS:
J1954
NDC(s):
69097-0909-50
Primary Type:
Oncology
Generic Status:
Single-Source
Route of Administration:
Intramuscular
About:
Leuprollide Depot is an Oncology drug manufactured by Cipla and administered via the Intramuscular route of administration. The J Code: J1954 is aligned to the drug Leuprollide Depot.